UCCELLI, Licia
 Distribuzione geografica
Continente #
NA - Nord America 16.006
AS - Asia 10.028
EU - Europa 6.107
SA - Sud America 1.715
AF - Africa 276
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 7
Totale 34.187
Nazione #
US - Stati Uniti d'America 15.571
SG - Singapore 3.763
CN - Cina 2.412
IT - Italia 1.601
BR - Brasile 1.354
VN - Vietnam 1.233
DE - Germania 833
HK - Hong Kong 788
UA - Ucraina 684
PL - Polonia 650
GB - Regno Unito 627
TR - Turchia 481
FI - Finlandia 408
FR - Francia 302
JP - Giappone 298
SE - Svezia 247
IN - India 245
RU - Federazione Russa 214
CA - Canada 196
MX - Messico 185
ID - Indonesia 151
BD - Bangladesh 127
ZA - Sudafrica 116
AR - Argentina 112
NL - Olanda 103
IQ - Iraq 83
BE - Belgio 73
ES - Italia 72
AT - Austria 56
CO - Colombia 53
EC - Ecuador 52
VE - Venezuela 51
PK - Pakistan 50
IR - Iran 46
LT - Lituania 45
AU - Australia 43
UZ - Uzbekistan 41
MY - Malesia 37
CL - Cile 33
SA - Arabia Saudita 33
MA - Marocco 31
CH - Svizzera 30
CZ - Repubblica Ceca 29
PH - Filippine 29
KR - Corea 26
TN - Tunisia 26
EG - Egitto 23
AE - Emirati Arabi Uniti 20
BG - Bulgaria 20
JO - Giordania 19
PY - Paraguay 19
TW - Taiwan 19
BO - Bolivia 17
HU - Ungheria 16
AZ - Azerbaigian 15
DK - Danimarca 14
IL - Israele 14
TH - Thailandia 14
KE - Kenya 13
RO - Romania 13
CR - Costa Rica 12
DZ - Algeria 12
ET - Etiopia 12
KG - Kirghizistan 12
PT - Portogallo 12
NP - Nepal 11
UY - Uruguay 11
LB - Libano 9
IE - Irlanda 8
KZ - Kazakistan 8
SY - Repubblica araba siriana 8
DO - Repubblica Dominicana 7
LV - Lettonia 7
PE - Perù 7
BY - Bielorussia 6
CY - Cipro 6
JM - Giamaica 6
AO - Angola 5
EU - Europa 5
HN - Honduras 5
NI - Nicaragua 5
OM - Oman 5
AL - Albania 4
CG - Congo 4
GR - Grecia 4
GY - Guiana 4
HR - Croazia 4
MK - Macedonia 4
NG - Nigeria 4
NO - Norvegia 4
PA - Panama 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
SV - El Salvador 4
AM - Armenia 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
KW - Kuwait 3
LY - Libia 3
Totale 34.122
Città #
Singapore 2.359
Ashburn 1.854
San Jose 1.133
Woodbridge 1.068
Fairfield 923
Chandler 805
Houston 769
Hong Kong 767
Beijing 738
Jacksonville 721
Santa Clara 721
Ann Arbor 686
Warsaw 632
Wilmington 381
Ho Chi Minh City 380
Ferrara 351
Seattle 336
Dallas 333
Los Angeles 308
New York 286
Tokyo 281
Hanoi 277
Cambridge 264
Nanjing 260
Izmir 257
The Dalles 241
Munich 220
Addison 194
Lauterbourg 182
Princeton 181
Helsinki 165
Council Bluffs 161
Milan 161
São Paulo 149
Boardman 128
Mexico City 112
Shanghai 112
Dearborn 99
Orem 90
Turku 90
San Diego 87
Jakarta 84
Buffalo 83
Dong Ket 81
London 79
Bologna 73
Shenyang 73
Johannesburg 70
Montreal 67
Nanchang 67
Rome 67
Chennai 66
Chicago 65
Tianjin 65
Brooklyn 64
Bremen 58
Brussels 58
Denver 57
Frankfurt am Main 57
Da Nang 56
Redwood City 55
Hefei 54
Stockholm 51
Changsha 49
Toronto 49
Boston 48
Hebei 48
Nuremberg 48
Phoenix 47
Haiphong 46
Poplar 46
Atlanta 45
Amsterdam 41
Rio de Janeiro 41
Moscow 40
Falls Church 35
Tashkent 35
Baghdad 34
San Francisco 34
Jiaxing 32
Vienna 31
Ankara 30
Jinan 30
Manchester 28
Kunming 27
Augusta 26
Brasília 26
Belo Horizonte 25
Guangzhou 25
Istanbul 25
Reggio Nell'emilia 25
San Mateo 25
Mountain View 24
Auburn Hills 23
Falkenstein 23
Biên Hòa 22
Curitiba 22
Chengdu 21
Lahore 21
Monmouth Junction 21
Totale 21.930
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 511
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 385
Proactive Implementation of Quantitative Analysis of the Risk FMEA / FMECA in Nuclear Medicine Procedures 343
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 334
Biodistribution of nanostructured lipid carriers: a tomographic study 325
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 316
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 315
Sterilità e asepsi: metodologie, convalide e verifiche 307
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 287
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 285
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 284
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 277
A solvent-extraction module for cyclotron production of high-purity technetium-99m 270
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 266
YAP-(S)PET small animal scanner: Quantitative results 250
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 248
Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations 247
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 239
Convalida del processo in asepsi(test Media Fill): preparazioni ottenute a mezzo kit 239
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 233
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients 233
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 231
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 230
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 222
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 220
Sampling considerations for high resolution small animal SPECT 219
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 219
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 218
Fractionation of radiopharmaceuticals: set-up and verification of an automatic system portable with integrated dose calibrator 216
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 214
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 214
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 213
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 211
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 210
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 209
A small animal hybrid PET-SPECT scanner: First in-vivo results. 208
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 206
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 204
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 203
Co-ordination chemistry of S-methyl 2-methyldithiocarbazate and formation of [M≡N]2+(M = Tc or Re) species 201
Tc(IV)Cl4(PPh3)2 and Tc(III)Cl3(CH3CN)(PPh3)2 as precursors of trans dioxo technetium(V) complexes with chelating amines and tetraazamacrocycles 200
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma 198
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 196
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 196
Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging 195
Extraction techniques of 99mTc from 100Mo Metal Target 195
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 194
Nitrido-technetium and -rhenium Complexes with Chelating Phosphines: Synthesis, Reactivity and Crystal Structures 194
Technetium complexes with ligands of pharmacological interest 193
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 192
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 189
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 189
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 187
Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolism 187
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 185
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 184
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 184
Development of a β-spectrometer for 99gTc Activity Estimations 183
Imaging of the scrotum: beyond sonography 180
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 179
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 179
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 177
188W/188Re generator system and its therapeutic applicacions 176
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 175
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 175
Rolling in the Deep: Imaging Findings and Diagnostic Pearls in Gallstone Ileus 174
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 174
Dosimetry of 177Lu-PSMA-617 after mannitol infusion and glutamate tablet administration: Preliminary results of EUDRACT/RSO 2016-002732-32 IRST protocol 173
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 171
Underestimation of regional myocardial perfusion with Tc-99m sestamibi single-day rest/stress SPECT: a “drug washout” pitfall? 171
99Tc≡N/ 99mTc≡N-complexes with aminoacids, synthesis, and crystal structure of [ 99TcNCl (CYS-OEt) (PPh 3)] 171
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 171
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 170
Advances in radiopharmaceuticals for cardiac imaging: 99mTcN-NOET 170
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 170
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 169
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 168
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 168
Coordination chemistry of S-methyl,N-methyldithiocarbazate and formation of [M≡N]2+ (M = Tc, Re) species. 166
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 165
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 165
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 164
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 164
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 163
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 162
Produzione e verifiche di qualità dei radiofarmaci prodotti mediante kit 160
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 160
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 158
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 158
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 158
Best Practices on Radiology Department Workflow: Tips from the Impact of the COVID-19 Lockdown on an Italian University Hospital 158
Evaluation of 99Mo and 99mTc Productions Based on a High-Performance Cyclotron 157
Methodology and technical implementation of a procedure for automated production 68Ga-DOTATOC 155
Validation of 99mTc and 177Lu quantification parameters for a Monte Carlo modelled gamma camera 154
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 154
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 154
Approccio diagnostico integrato alla nodularità singola della tiroide 154
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 154
Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent 153
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 153
Totale 20.653
Categoria #
all - tutte 142.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.432
Totale 154.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021826 0 0 0 0 0 0 0 0 0 324 322 180
2021/20222.016 82 164 132 106 115 82 109 109 82 159 274 602
2022/20231.927 218 153 51 231 275 273 103 179 209 24 136 75
2023/20241.348 100 129 140 49 89 187 70 98 48 41 73 324
2024/20255.796 175 170 414 235 618 389 265 326 887 687 1.051 579
2025/202614.052 1.387 563 1.248 1.957 2.251 1.017 1.853 930 1.420 1.426 0 0
Totale 34.615